Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02980835 · ClinicalTrials.gov registry record · Phase 4

Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries

A Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery, sponsored by University at Buffalo.

Completed
Registry status
Phase 4
Development phase
36
Enrollment target
1
Study location

NCT02980835 is a Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery that has completed, run by University at Buffalo. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02980835, a Phase 4 study of Video Assisted Thoracoscopic Surgery and Video-Assisted Thoracic Surgery, has completed, sponsored by University at Buffalo.

COMPLETED
Registry status
Phase 4
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

Intercostal nerve block, performed under the guidance of videoscope, is a part of standard anesthesia procedures for patients receiving Video-Assisted Thoracic Surgeries. In this double-blind, prospective, multi-center, randomized, controlled clinical trial the investigators aim to compare preemptive versus post-closure intercostal injection of ropivacaine in controlling post-video-assisted thoracotomy pain.

Interventions

  • DRUG Dexamethasone
  • DRUG Epinephrine
  • DRUG Normal Saline
  • DRUG Ropivacaine

Study Locations (1)

New York

  • VA Western New York Healthcare System - Buffalo

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2016-09-28
Est. Completion 2022-03-30
Phase Phase 4

Sponsor

University at Buffalo

67 total trials

What the Registry Record Tells You About NCT02980835

The ClinicalTrials.gov registry entry for NCT02980835 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Video Assisted Thoracoscopic Surgery appearing as the primary indexed condition, and to 4 interventions - of which Dexamethasone is the first listed.

NCT02980835 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02980835 about?

NCT02980835 is a clinical study titled "Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries". Intercostal nerve block, performed under the guidance of videoscope, is a part of standard anesthesia procedures for patients receiving Video-Assisted Thoracic Surgeries. In this double-blind, prospective, multi-center, randomized, controlled clinical trial the investigators aim to compare preemptiv...

What is the current status of trial NCT02980835?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2016-09-28. Estimated completion is 2022-03-30.

What conditions does trial NCT02980835 study?

This clinical trial studies the following conditions: Video Assisted Thoracoscopic Surgery, Video-Assisted Thoracic Surgery.

What interventions are being tested in trial NCT02980835?

The interventions under investigation include: Dexamethasone (DRUG), Epinephrine (DRUG), Normal Saline (DRUG), Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT02980835?

This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02980835 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Video Assisted Thoracoscopic Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.